SAHAREK JOHN P. 4
4 · HARROW, INC. · Filed Mar 6, 2024
Insider Transaction Report
Form 4
HARROW, INC.HROW
SAHAREK JOHN P.
CEO & President, ImprimisRx
Transactions
- Exercise/Conversion
Common stock
2024-03-01$8.75/sh+5,000$43,750→ 254,803 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-01−5,000→ 0 totalExercise: $8.75Exp: 2024-03-03→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024.